Nurse Practitioner, Family · Fort Wayne, IN
NPI
1801064266
Since 2008
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
7900 W Jefferson Blvd, Suite 201
Fort Wayne, IN, 46804
Phone (260) 432-2297
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
1,335 services
Medicare patients, 2024
306
Average age 71
Drug cost, 2024
$2.4M
4,357 prescriptions
Company payments, 2025
$2,689
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brenda S Wiley was code 99214 (office e&m - established), 287 times for 129 patients. In total Brenda S Wiley billed 1,335 services in 16 codes, and Medicare paid $57K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-09-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 287 | 129 | $68.51 | $20K |
| 99232 Hospital E&M - Subsequent | Facility | 212 | 104 | $48.28 | $10K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 197 | 100 | $9.96 | $1,963 |
| 99231 Hospital E&M - Subsequent | Facility | 195 | 89 | $30.27 | $5,902 |
| 95251 Test - Miscellaneous | Office | 142 | 58 | $19.90 | $2,825 |
| 83036 Blood Count | Office | 122 | 80 | $9.13 | $1,114 |
| 99222 Hospital E&M - Initial | Facility | 90 | 87 | $80.45 | $7,241 |
| 99213 Office E&M - Established | Office | 14 | 12 | $40.79 | $571 |
By year: 2022 $66K for 1,693 services; 2023 $62K for 1,328 services; 2024 $57K for 1,335 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 122 | 80 | $9.13 | $1,114 |
Medicare prescription drug claims, 2024
In 2024, the drug Brenda S Wiley prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 377 prescriptions and refills. In total Brenda S Wiley wrote 4,357 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 377 | 482 | 64 | $513K |
| Levothyroxine Sodium Generic | 328 | 921 | 90 | $2,419 |
| Metformin Hcl Generic | 226 | 627 | 70 | $1,324 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 181 | 424 | 68 | $44K |
| Ozempic Semaglutide | 160 | 273 | 40 | $265K |
| Atorvastatin Calcium Generic | 122 | 320 | 31 | $1,190 |
| Gabapentin Generic | 119 | 328 | 39 | $2,943 |
| Humalog Kwikpen U-100 Insulin Lispro | 116 | 237 | 54 | $46K |
| Jardiance Empagliflozin | 96 | 227 | 24 | $137K |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 86 | 144 | 28 | $25K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 83 | 203 | 42 | $15K |
| Rosuvastatin Calcium Generic | 77 | 234 | 27 | $829 |
| Novolog Flexpen Insulin Aspart | 72 | 141 | 35 | $28K |
| Glimepiride Generic | 70 | 167 | 18 | $739 |
| Humalog Insulin Lispro | 70 | 139 | 18 | $26K |
Brand drugs: 2,318 claims; generic drugs: 1,625 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brenda S Wiley $2,689 ($2,689 in general payments such as food, travel and fees) from 31 companies. The largest payer was Senseonics, Incorporated with $800.
| Company | Payments | Amount |
|---|---|---|
| Senseonics, Incorporated SENS | 2 | $800 |
| Tandem Diabetes Care, Inc. TNDM | 12 | $223 |
| Lilly USA, LLC LLY | 19 | $213 |
| Medtronic, Inc. MDT | 9 | $165 |
| Amgen Inc. AMGN | 14 | $149 |
| Abbott Laboratories ABT | 8 | $140 |
| Xeris Pharmaceuticals, Inc. | 6 | $108 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $70.79 |
| Beta Bionics, Inc. BBNX | 3 | $67.81 |
| Alexion Pharmaceuticals, Inc. AZN | 3 | $61.42 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.